MiniMed Group, Inc. (MMED)

MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 25, 2025	Apr 25, 2024	Apr 25, 2023
Revenue	2,886	2,715	2,469	2,245
Revenue Growth (YoY)	-	9.96%	9.98%	-
Cost of Revenue	-	1,187	1,032	937
Gross Profit	1,638	1,528	1,436	1,308
Selling, General & Admin	-	1,080	1,057	960
Research & Development	-	436	437	429
Other Operating Expenses	0	158	11	-12
Operating Expenses	-	1,674	1,505	1,377
Operating Income	-123	-146	-69	-69
Other Expense (Income)	1	-	-	7
Pretax Income	-139	-161	-74	-80
Income Tax	72	52	38	16
Net Income	-196	-198	-107	-92
Net Income Common	-211	-213	-112	-96
Free Cash Flow	-207	-53	-107	-173
Gross Margin	56.76%	56.28%	58.16%	58.26%
Operating Margin	-4.26%	-5.38%	-2.79%	-3.07%
Profit Margin	-7.31%	-7.85%	-4.54%	-4.28%
Free Cash Flow Margin	-7.17%	-1.95%	-4.33%	-7.71%
EBITDA	29	-3	60	39
EBITDA Margin	1.00%	-0.11%	2.43%	1.74%
Depreciation & Amortization	153	143	129	115
EBIT	-124	-146	-69	-76
EBIT Margin	-4.30%	-5.38%	-2.79%	-3.38%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).